Cargando…

Comparison of clinical outcomes in patients with schizophrenia following different long-acting injectable event-driven initiation strategies

This retrospective study evaluated the benefit of following different long-acting injectable (LAI) initiation strategies based on the timing of behavioral and clinical events among Medicaid beneficiaries with schizophrenia. Adults with schizophrenia initiating oral antipsychotics (OAPs) after 12 mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Correll, Christoph U., Benson, Carmela, Emond, Bruno, Patel, Charmi, Lafeuille, Marie-Hélène, Lin, Dee, Morrison, Laura, Ghelerter, Isabelle, Lefebvre, Patrick, Mavros, Panagiotis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922270/
https://www.ncbi.nlm.nih.gov/pubmed/36774362
http://dx.doi.org/10.1038/s41537-023-00334-3
_version_ 1784887507777748992
author Correll, Christoph U.
Benson, Carmela
Emond, Bruno
Patel, Charmi
Lafeuille, Marie-Hélène
Lin, Dee
Morrison, Laura
Ghelerter, Isabelle
Lefebvre, Patrick
Mavros, Panagiotis
author_facet Correll, Christoph U.
Benson, Carmela
Emond, Bruno
Patel, Charmi
Lafeuille, Marie-Hélène
Lin, Dee
Morrison, Laura
Ghelerter, Isabelle
Lefebvre, Patrick
Mavros, Panagiotis
author_sort Correll, Christoph U.
collection PubMed
description This retrospective study evaluated the benefit of following different long-acting injectable (LAI) initiation strategies based on the timing of behavioral and clinical events among Medicaid beneficiaries with schizophrenia. Adults with schizophrenia initiating oral antipsychotics (OAPs) after 12 months without antipsychotic use or schizophrenia-related inpatient/emergency room (ER) visits (index date) were identified. Patients were categorized into four event-driven LAI initiation strategy cohorts based on observed sequences of behavioral (i.e., OAP adherence) and clinical (i.e., schizophrenia-related inpatient/ER visits) events between index and LAI initiation or censoring—strategy #1: adherent to OAPs without schizophrenia-related inpatient/ER visits; strategy #2: nonadherent to OAPs without schizophrenia-related inpatient/ER visits; strategy #3: one schizophrenia-related inpatient/ER visit; strategy #4: ≥2 schizophrenia-related inpatient/ER visits. Clinical outcomes (i.e., all-cause inpatient/ER visits) were evaluated between OAP initiation and end of follow-up. Comparisons between LAI initiation strategy cohorts were conducted using a dynamic marginal structural model adjusting for baseline characteristics and time-varying confounders. Among 13,444 eligible patients, 13.1%, 53.6%, 15.7%, and 17.6% were following strategies #1–4, respectively; of these, 21.9%, 4.3%, 9.2%, and 6.5% started an LAI (the remaining were censored). Strategy #1 was associated with a greater clinical benefit, with 43%, 69%, and 80% fewer inpatient days (all p < 0.05); and 57%, 59%, and 79% fewer ER visits (all p < 0.01) vs strategies #2–4, respectively; the clinical benefit was also observed for strategy #2 vs #3–4. Therefore, starting an LAI prior to OAP nonadherence or occurrence of a schizophrenia-related inpatient/ER visit was associated with fewer all-cause inpatient days of inpatient stay and ER visits.
format Online
Article
Text
id pubmed-9922270
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-99222702023-02-13 Comparison of clinical outcomes in patients with schizophrenia following different long-acting injectable event-driven initiation strategies Correll, Christoph U. Benson, Carmela Emond, Bruno Patel, Charmi Lafeuille, Marie-Hélène Lin, Dee Morrison, Laura Ghelerter, Isabelle Lefebvre, Patrick Mavros, Panagiotis Schizophrenia (Heidelb) Article This retrospective study evaluated the benefit of following different long-acting injectable (LAI) initiation strategies based on the timing of behavioral and clinical events among Medicaid beneficiaries with schizophrenia. Adults with schizophrenia initiating oral antipsychotics (OAPs) after 12 months without antipsychotic use or schizophrenia-related inpatient/emergency room (ER) visits (index date) were identified. Patients were categorized into four event-driven LAI initiation strategy cohorts based on observed sequences of behavioral (i.e., OAP adherence) and clinical (i.e., schizophrenia-related inpatient/ER visits) events between index and LAI initiation or censoring—strategy #1: adherent to OAPs without schizophrenia-related inpatient/ER visits; strategy #2: nonadherent to OAPs without schizophrenia-related inpatient/ER visits; strategy #3: one schizophrenia-related inpatient/ER visit; strategy #4: ≥2 schizophrenia-related inpatient/ER visits. Clinical outcomes (i.e., all-cause inpatient/ER visits) were evaluated between OAP initiation and end of follow-up. Comparisons between LAI initiation strategy cohorts were conducted using a dynamic marginal structural model adjusting for baseline characteristics and time-varying confounders. Among 13,444 eligible patients, 13.1%, 53.6%, 15.7%, and 17.6% were following strategies #1–4, respectively; of these, 21.9%, 4.3%, 9.2%, and 6.5% started an LAI (the remaining were censored). Strategy #1 was associated with a greater clinical benefit, with 43%, 69%, and 80% fewer inpatient days (all p < 0.05); and 57%, 59%, and 79% fewer ER visits (all p < 0.01) vs strategies #2–4, respectively; the clinical benefit was also observed for strategy #2 vs #3–4. Therefore, starting an LAI prior to OAP nonadherence or occurrence of a schizophrenia-related inpatient/ER visit was associated with fewer all-cause inpatient days of inpatient stay and ER visits. Nature Publishing Group UK 2023-02-11 /pmc/articles/PMC9922270/ /pubmed/36774362 http://dx.doi.org/10.1038/s41537-023-00334-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Correll, Christoph U.
Benson, Carmela
Emond, Bruno
Patel, Charmi
Lafeuille, Marie-Hélène
Lin, Dee
Morrison, Laura
Ghelerter, Isabelle
Lefebvre, Patrick
Mavros, Panagiotis
Comparison of clinical outcomes in patients with schizophrenia following different long-acting injectable event-driven initiation strategies
title Comparison of clinical outcomes in patients with schizophrenia following different long-acting injectable event-driven initiation strategies
title_full Comparison of clinical outcomes in patients with schizophrenia following different long-acting injectable event-driven initiation strategies
title_fullStr Comparison of clinical outcomes in patients with schizophrenia following different long-acting injectable event-driven initiation strategies
title_full_unstemmed Comparison of clinical outcomes in patients with schizophrenia following different long-acting injectable event-driven initiation strategies
title_short Comparison of clinical outcomes in patients with schizophrenia following different long-acting injectable event-driven initiation strategies
title_sort comparison of clinical outcomes in patients with schizophrenia following different long-acting injectable event-driven initiation strategies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922270/
https://www.ncbi.nlm.nih.gov/pubmed/36774362
http://dx.doi.org/10.1038/s41537-023-00334-3
work_keys_str_mv AT correllchristophu comparisonofclinicaloutcomesinpatientswithschizophreniafollowingdifferentlongactinginjectableeventdriveninitiationstrategies
AT bensoncarmela comparisonofclinicaloutcomesinpatientswithschizophreniafollowingdifferentlongactinginjectableeventdriveninitiationstrategies
AT emondbruno comparisonofclinicaloutcomesinpatientswithschizophreniafollowingdifferentlongactinginjectableeventdriveninitiationstrategies
AT patelcharmi comparisonofclinicaloutcomesinpatientswithschizophreniafollowingdifferentlongactinginjectableeventdriveninitiationstrategies
AT lafeuillemariehelene comparisonofclinicaloutcomesinpatientswithschizophreniafollowingdifferentlongactinginjectableeventdriveninitiationstrategies
AT lindee comparisonofclinicaloutcomesinpatientswithschizophreniafollowingdifferentlongactinginjectableeventdriveninitiationstrategies
AT morrisonlaura comparisonofclinicaloutcomesinpatientswithschizophreniafollowingdifferentlongactinginjectableeventdriveninitiationstrategies
AT ghelerterisabelle comparisonofclinicaloutcomesinpatientswithschizophreniafollowingdifferentlongactinginjectableeventdriveninitiationstrategies
AT lefebvrepatrick comparisonofclinicaloutcomesinpatientswithschizophreniafollowingdifferentlongactinginjectableeventdriveninitiationstrategies
AT mavrospanagiotis comparisonofclinicaloutcomesinpatientswithschizophreniafollowingdifferentlongactinginjectableeventdriveninitiationstrategies